Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can mouth and face exercises reshape how kids swallow and breathe?

NCT ID NCT07828769

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 18, 2026 · Last updated Sep 18, 2026

Summary

Researchers in Estonia are studying whether eight months of orofacial myofunctional therapy can improve mouth and face function in children and adolescents aged 7 to 14 who have orofacial myofunctional disorders. Participants attend eight therapy sessions and practice tailored exercises at home once a day, targeting tongue and lip strength, swallowing, tongue posture, and nasal breathing. The study measures changes in muscle activity during swallowing and in tongue strength using standardized clinical tools, and it tracks how these changes relate to facial structure and how closely participants follow the program.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
orofacial myofunctional therapy, a structured exercise program for the mouth and face
What this could lead to
If it works, this could give families and clinicians clearer evidence that structured mouth and face exercises improve tongue strength, swallowing, and breathing in children with these disorders.
What could go wrong
The study is small and has no comparison group, so improvements may reflect normal growth or extra attention rather than the therapy itself. Children must practice daily at home, and results may not apply to other ages or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

7 to 14 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 7-14 years at the time of enrollment. * Referred for orofacial myofunctional therapy. * Diagnosed with an orofacial myofunctional disorder. * Willingness to participate in therapy and assessments according to the study protocol. * Written informed consent from a parent or legal guardian for the child's participation in the study. * Written informed assent from the child to participate in the study. * Written consent from a parent or legal guardian to participate in the study by completing the questionnaire assessing their child's treatment adherence. * Sufficient proficiency in Estonian to participate in the study and understand the study procedures. Exclusion Criteria: * Structural craniofacial anomalies or syndromes (e.g., cleft lip and/or palate). * A medical condition that prevents safe participation in therapy or study assessments.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Orofacial myofunctional disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Treatment Adherence and Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Tartu University Hospital, Clinic of Dentistry

    Tartu, 50406, Estonia

More trials for these conditions

Other studies related to the condition(s) this trial covers.